The Latest
-
Oracle launches AI-backed EHR
The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.
-
Cardiosense appoints John Martin as chief medical officer
The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.
-
Draeger removes ventilation filters over misleading carbon dioxide readings
Hospitals are being advised to stop using the filters after serious injuries were reported related to the problem, the FDA said in a recall notice.
-
SetPoint Medical secures $140M to fund neuromodulation for arthritis
Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.
-
Heartflow’s IPO raises $364M
The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.
-
Hospitals prepare for $149B cut to Medicaid state-directed payments
New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured patients.
-
US to maintain lower tariff rates on China imports for 90 more days
China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.
-
Apreo raises $130M for pivotal trial of emphysema device
The company, which received investment from the venture capital wing of Intuitive Surgical, has designed the device to work in a broader patient population than existing treatments.
-
Boston Scientific updates instructions of devices linked to 17 deaths
The update covers devices used in procedures to implant the company’s Watchman heart device.
-
Tandem, Insulet monitoring CMS payment proposal for diabetes tech
The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.
-
Tandem insulin pump malfunction linked to 59 injuries
A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.
-
Masimo appoints several senior execs, resolves cyber incident
The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but investors have raised questions about the status of a partnership with Philips.
-
Boston Scientific tells users about defibrillator problem linked to deaths, injuries
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.
-
FTC moves to block Edwards’ JenaValve acquisition
Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.
-
Zimmer is latest medtech firm to lower expected tariff hit
CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million to $80 million.
-
Trump plans 100% tariffs for semiconductor imports
Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.
-
BD commits $35M to expand US syringe production plant
The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to above 750 million units.
-
Medical device industry says future MDUFA hikes unsustainable
Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for postmarket safety.
-
Alcon to acquire STAAR Surgical for about $1.5B
BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.
-
Philips BiPAP machine recall associated with 8 deaths
Philips sent updated instructions after disclosing problems last year with an alarm that can interrupt treatment for people with obstructive sleep apnea or respiratory insufficiency.